Randomized trial demonstrates DBT reduces suicidality in borderline personality disorder, suggesting it may be preferable to SSRIs.
Six months of dialectical behavior therapy (DBT) was more efficacious than a 6‐month course of treatment with a selective serotonin reuptake inhibitor (SSRI) antidepressant in reducing suicide‐related events in patients with borderline personality disorder, a randomized trial has found. However, SSRI treatment was more efficacious than DBT in reducing diagnoses of major depressive disorder at 6 months.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: